The forecast for chronic liver diseases and cirrhosis mortality in Canada indicates a gradual increase in female deaths from 2024 to 2028. In 2023, the mortality stood at an actual value lower than the forecasted 1.44 thousand female deaths in 2024. Year-on-year variations suggest a consistent upward trend, with average increments projected over these years. The compound annual growth rate (CAGR) over the five-year period suggests a steady rise in mortality rates, reflecting potential underlying health trends.
Looking ahead, future trends to watch include the impact of public health initiatives on liver disease prevention, potential advancements in medical treatment, and shifts in population demographics that might influence mortality rates. Monitoring these elements is crucial for healthcare planning and policy development to address this rising health concern in Canada.
